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Hess: NGO Update

NGO UPDATE
To foster communication among human
rights organizations around the world, each
issue of the Human Rights Brief features an
“NGO Update.” This space was created to
aid non-governmental organizations (NGOs)
by informing others about their programs,
successes, and challenges.
The Institute for
OneWorld Health
www.oneworldhealth.org
The Institute for OneWorld Health is a
nonprofit pharmaceutical company whose
mission is to develop safe, effective, and
affordable new medicines for people with
infectious diseases in the developing world.
Access to doctors and medicine and the right
to affordable health care have been evolving
principles of human rights since the United
Nations adopted the Universal Declaration of
Human Rights in 1948. With the recent
explosion of the pharmaceutical industry in
the developed world, the prevailing model of
medicine is a business model driven by profit.
OneWorld Health is challenging this by
establishing a nonprofit model of drug development driven by the neglected health needs
of people in the developing world.
Dr. Victoria G. Hale founded OneWorld
Health in July 2000 in San Francisco,
California in an effort to address the gap in
human need, scientific effort, and the marketplace. OneWorld Health has five general
roles: identifying potential new medicines for
diseases affecting developing countries; assessing the safety and effectiveness of investigational medicines; honoring international ethical standards for research; establishing collaborations with partners to manufacture and
distribute new medicines; and ensuring that
medicines will be affordable and available
for distribution.
OneWorld Health is the first nonprofit
pharmaceutical company in the United
States. The NGO tests the prevailing business
model of pharmaceutical research and development by partnering with the industry sector and researchers. In an effort to decrease
costs of production, OneWorld secures
donated intellectual property and utilizes the
scientific and manufacturing capacity of the

developing world in order to deliver affordable and effective medicine where these
resources are needed most.
On September 19, 2006, the John D. and
Catherine T. MacArthur Foundation named
Dr. Hale a 2006 MacArthur Fellow.
MacArthur Fellowships are awarded to individuals who have developed original and creative ideas through which they can potentially make significant contributions to the
world. The MacArthur Foundation through
an unsolicited, meticulous review process
chooses 20 to 25 Fellows each year. Each
Fellow receives an unrestricted grant of
$500,000 distributed over the course of five
years. The MacArthur Foundation recognized
Dr. Hale as a Pharmaceutical Entrepreneur
for her creation of OneWorld Health and her
significant contribution to medicine in developing countries. In addition to being named a
MacArthur Fellow, Dr. Hale has also been
selected as a 2006 Ashoka Senior Fellow for
leading work in social innovation, as well as
being selected Esquire Magazine’s Executive
of the Year in 2005. The MacArthur
Fellowship came only days after OneWorld
Health achieved international attention for
the approval of one of its most recent research
projects. On September 8, 2006 the Drug
Controller General of India approved
Paromomycin Intramuscular Injection for
the treatment of Visceral Leishmaniasis (VL).
VL is the second most deadly parasitic disease
in the world following malaria. The treatment for VL was approved less than three
months after OneWorld Health submitted
the drug’s application.
In the last decade the relationship between
the pharmaceutical industry and the developing world has gained significant international
attention, most of which has been negative.
Dr. Hale and OneWorld Health illustrate a
significant shift in the way people view the
pharmaceutical industry. If a nonprofit business model can successfully deliver current
and future medicine and medical technology
to the developing world, the potential impact
is immense. As scientists continue to develop
new medicines, OneWorld Health represents
a possible future that is hopeful for human
rights and the millions of people in need in
the developing world.
49

The Amy Biehl Foundation
www.amybiehl.org
Unlike many human rights NGOs, the
Amy Biehl Foundation grew out of a personal
tragedy. In 1993, Amy Biehl, a dynamic, intelligent, and compassionate human rights advocate and student was working in South Africa
when she was viciously murdered by an angry
mob in the Guguletu Township. Amy’s parents, Linda and Peter Biehl, faced the challenge of addressing the tragedy of Amy’s
death. Linda remembers that she and her husband wanted to respond positively and
express their love and support for their daughter and her work. In the wake of Amy’s death,
the Biehls were invited to South Africa and
ultimately asked to be part of Archbishop
Desmond Tutu’s Truth and Reconciliation
Commission (TRC). What started as love and
support for their daughter quickly grew into
love and support for South Africa.
A major theme of Amy Biehl’s work, and
that behind the TRC, was restorative justice.
Restorative justice focuses on repairing the
harm done by crime and rebuilding the
impacted communities. In consideration of
this, The Biehls supported the granting of
amnesty for the men that murdered Amy.
Two of the young men granted amnesty later
worked as employees of the Amy Biehl
Foundation Trust, helping deliver loaves of
“Amy’s Bread: The Bread of Hope and Peace.”
In 1997, in support of South Africa’s postapartheid advances, the Biehls founded the
Amy Biehl Foundation Trust (ABFT), a nonprofit organization in South Africa, and the
Amy Biehl Foundation (ABF), a non-profit
organization in the United States. The ABFT
is a grassroots, community based organization
in South Africa that provides students with
the preparation to pursue higher education or
to acquire marketable skills. The ABFT leads
and supports community-based programs
that cover a wide variety of social issues,
including education, micro enterprise development, health and safety, and the environment. A sampling of ABFT programs
includes: teaching first-aid classes in South
African prisons; educating the public about
HIV and AIDS; supporting music and theatre
outreach projects; and developing a series of
after-school care programs.
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The ABF is an American NGO that was
created primarily to serve as a fundraising
mechanism for the ABFT. However, the ABF
has also become an active restorative justice
program. Each year Linda Biehl and colleagues travel the United States, sharing stories and teaching youth about restorative justice. The ABF also supports interns both in
the United States and in South Africa. Linda
Biehl views ABF’s work as facilitating restorative justice and educating America’s youth.
The ABF works to teach American students

the value of other cultures and listening skills.
Through the ABF and the ABFT, Amy Biehl’s
legacy continues. As South Africa continues
to emerge as a new democracy, the NGOs
create a setting for students in the U.S. and
South Africa to learn about restorative
justice and appreciate the lessons of other
cultures.
HRB
Jerald Hess, a J.D. candidate at the Washington
College of Law, covers the NGO Update for the
Human Rights Brief.
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